|
|
Rheumatoid Arthritis Safety
Clifton Bingham, M.D.
L43. The Efficacy and Safety of Abatacept or Infliximab in RA Patients with an Inadequate response to MTX: Results from a 1-year Double-blind, Randomized, Placebo-controlled Trial
All
information contained within the Johns Hopkins Arthritis Center website
is intended for educational purposes only. Physicians and other health care
professionals are encouraged to consult other sources and confirm the information
contained within this site. Consumers should never disregard medical advice
or delay in seeking it because of something they may have read on this website.
|
